Richard Rouder
Foot Surgery · Scotch Plains, NJNPI 1598704488
Payments from drug & device makers
What this record shows
14 manufacturers reported payments, led by Medimetriks Pharmaceuticals, Inc. at 53.2% of the total.
Across 30 payments — averaging $45.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medimetriks Pharmaceuticals, Inc.$719
- Treace Medical Concepts, Inc.$119
- Paratek Pharmaceuticals, Inc.$100
- Ortho Dermatologics, A Division Of Bausch Health US, LLC$84
- Sebela Pharmaceuticals Inc.$77
- Tactile Systems Technology Inc$67
- plus $186 from 8 others
What the payments were for
- Consulting fees$70052%
- Food & beverage$65248%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medimetriks Pharmaceuticals, Inc. | 3 | $719 |
| Treace Medical Concepts, Inc. | 4 | $119 |
| Paratek Pharmaceuticals, Inc. | 2 | $100 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 5 | $84 |
| Sebela Pharmaceuticals Inc. | 5 | $77 |
| Tactile Systems Technology Inc | 3 | $67 |
| Bioventus LLC | 1 | $31 |
| Medtronic | 1 | $29 |
| AbbVie | 1 | $25 |
| Advanced Oxygen Therapy Inc. | 1 | $23 |
| Celularity Inc. | 1 | $23 |
| ANI Pharmaceuticals, Inc. | 1 | $18 |
| GRT US Holding, Inc. | 1 | $18 |
| Amgen | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Genadur$700
- Ketodan$700
- Neo-Synalar$700
How this compares
$1,352 in reported general payments places this provider in the 55th percentile of 59 foot surgery providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ciclopirox | 41 | $1,360 |
| Ketoconazole | 27 | $528 |
| Ammonium Lactate | 14 | $264 |
| Mupirocin | 31 | $199 |
| Terbinafine Hcl | 21 | $122 |
| Cefadroxil | 21 | $102 |
Paid to pharmacies, not to this prescriber.
Other foot surgery in Scotch Plains
- Steven GoldsteinLivingston$208K
- Paul SullivanMarlton$7K
- Timothy SorensenCape May Court House$5K
- Greg RubinsteinTeaneck$5K
- Christopher MullinAberdeen$5K
- Gary QuartelloBerkeley Hts$4K
- Graciani MartinezDover$4K
- James CancilleriNorthfield$4K
- Frank KillianToms River$3K
- Bowen YangHoboken$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.